Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F3NVM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $68,869
Award facts
- Contract value 100% obligated
- $68,869.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $68,869.23 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on November 12, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 13, 2025. No set-aside designation was applied to this award.
As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of federal contracts supplying brand-name and generic medications, vaccines, and specialized medical supplies to military and veteran healthcare systems. This delivery order for Dupixent—an immunosuppressant biologic indicated for conditions such as atopic dermatitis and eosinophilic disorders—exemplifies the company's role in supporting the Defense Health Agency and broader Department of Defense healthcare requirements. The award reflects DLA's continued reliance on AmerisourceBergen's capacity to fulfill pharmaceutical needs through flexible contract vehicles designed to serve multiple federal health systems globally.
Quick answers
Who was awarded contract SPE2DR26F3NVM?
SPE2DR26F3NVM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26F3NVM worth?
The government has obligated $68,869 on SPE2DR26F3NVM.
Is contract SPE2DR26F3NVM an order under another contract?
Yes. SPE2DR26F3NVM is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3NVM competed?
The extent of competition for SPE2DR26F3NVM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award